In all TTP patients, the activity of ADAMTS13 in the plasma decreases significantly (< 10%); and patients with iTTP often show the presence of ADAMTS13 inhibitors [5, 6]. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.